William Mack & Associates
RVMD icon

William Mack & Associates’s Revolution Medicines RVMD Stock Holding History

William Mack & Associates’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.44K Buy
+7
New +$1.39K ﹤0.01% 630

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

William Mack & Associates's RVMD Position: Q3 2026 in Review

William Mack & Associates opened a new position in Revolution Medicines (RVMD) in Q3 2026: 7 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #630 among its holdings.

577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • William Mack & Associates held 7 shares of Revolution Medicines worth $1.44K as of Q3 2026.
  • Revolution Medicines was a new William Mack & Associates position in Q3 2026.
  • Revolution Medicines made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #630 holding.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.